Researchers Submit Patent Application, "Mhc Class I Associated Peptides For Prevention And Treatment Of Multiple Flavi Virus", for Approval (USPTO 20230346908).
In: Zika & Mosquito Week, 2023-11-24, S. 2992-2992
serialPeriodical
Zugriff:
A patent application has been submitted for a vaccine composition that aims to prevent and treat multiple flavivirus infections, including Zika virus, Dengue virus, West Nile virus, yellow fever virus, and Japanese encephalitis virus. The vaccine composition utilizes a nanoparticle, such as a gold nanoparticle, to stimulate a T cell response against the flaviviruses, eliminating the need for a virus in the vaccine. The inclusion of conserved peptides in the vaccine composition may provide protection against multiple species and lineages of flaviviruses. This invention addresses the need for effective vaccines against these infections, as current vaccines are limited in their effectiveness and safety. [Extracted from the article]
Copyright of Zika & Mosquito Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Researchers Submit Patent Application, "Mhc Class I Associated Peptides For Prevention And Treatment Of Multiple Flavi Virus", for Approval (USPTO 20230346908).
|
---|---|
Zeitschrift: | Zika & Mosquito Week, 2023-11-24, S. 2992-2992 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
Schlagwort: |
|
Sonstiges: |
|